FIELD: biotechnology.
SUBSTANCE: invention relates to the use of a transgenic mouse with inducible expression of the Xenopus laevis xAG gene with a STOP cassette and under the control of a Tet-On promoter as a model animal for studying reparative skin wound regeneration.
EFFECT: invention provides the stimulation of the regenerative abilities of the created transgenic animal (model) under the influence of endogenous expression of regeneration factors active in lower vertebrate organisms.
1 cl, 6 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING A LINE OF HUMANISED MICE, TRANSGENIC BY hACE2 | 2020 |
|
RU2757114C1 |
| METHOD OF OBTAINING GENETICALLY MODIFIED LABORATORY ANIMALS WITH INDUCIBLE SYSTEMIC AND TISSUE-SPECIFIC EXPRESSION OF HUMAN CYCLOPHILIN A | 2022 |
|
RU2800264C1 |
| METHOD OF PRODUCING GENETICALLY MODIFIED MICE EXPRESSING HUMAN ANTITHROMBIN III MINIGENE USING MICROINJECTIONS OF TELN-LINEARIZED DNA FRAGMENT | 2022 |
|
RU2806568C1 |
| KIT FOR DETERMINING THE ABUNDANCE OF THE APP GENE IN THE HUMAN GENOME | 2021 |
|
RU2789799C1 |
| A SET FOR DETERMING THE ABUNDANCE OF THE INSERTIONOF THE CONSTRUCT OF INTEREST INTO THE AAVS1LOCUS OF THE HUMAN GENOME | 2021 |
|
RU2786396C1 |
| GENETICALLY ENGINEERED CONSTRUCT pGoatcasGCSF ENABLING HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION IN MILK OF TRANSGENIC ANIMALS | 2010 |
|
RU2422529C1 |
| LINE OF MICE TRANSGENIC ON AN ALPHA-CHAIN OF A T-CELL RECEPTOR OF MEMORY CELLS, TO STUDY THEIR FUNCTIONAL ACTIVITY | 2017 |
|
RU2691484C2 |
| TRANSGENIC ANIMAL THAT DIFFERS FROM HUMAN, AND ITS APPLICATION | 2010 |
|
RU2579701C2 |
| OBTAINING ANTIBODIES FROM SAME HEAVY CHAINS IN TRANSGENIC ANIMALS | 2007 |
|
RU2435784C2 |
| METHOD FOR OBTAINING A MOUSE MODEL FOR STUDYING LESCH-NYHAN SYNDROME BY INTRODUCING A DELETION OF P.Val8del INTO THE Hprtl GENE | 2021 |
|
RU2768048C1 |
